Somewhat Favorable News Coverage Somewhat Unlikely to Impact Align Technology (ALGN) Share Price

News coverage about Align Technology (NASDAQ:ALGN) has trended somewhat positive recently, according to Accern Sentiment. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Align Technology earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned press coverage about the medical equipment provider an impact score of 46.7546734076981 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

These are some of the news stories that may have effected Accern Sentiment’s scoring:

Align Technology (NASDAQ ALGN) traded up $5.65 on Wednesday, hitting $233.01. 1,215,400 shares of the company were exchanged, compared to its average volume of 1,023,886. The stock has a market capitalization of $18,104.13, a P/E ratio of 66.81, a price-to-earnings-growth ratio of 2.16 and a beta of 1.43. Align Technology has a one year low of $88.56 and a one year high of $266.41.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Thursday, October 26th. The medical equipment provider reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.82 by $0.19. The company had revenue of $385.30 million for the quarter, compared to the consensus estimate of $359.80 million. Align Technology had a net margin of 19.98% and a return on equity of 25.60%. The firm’s revenue was up 38.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.63 earnings per share. analysts forecast that Align Technology will post 3.62 EPS for the current fiscal year.

ALGN has been the topic of a number of recent analyst reports. Leerink Swann reaffirmed an “outperform” rating and set a $250.00 price target on shares of Align Technology in a report on Friday, October 27th. Zacks Investment Research raised shares of Align Technology from a “hold” rating to a “buy” rating and set a $227.00 price target on the stock in a report on Monday, October 30th. Credit Suisse Group raised their price target on shares of Align Technology from $175.00 to $209.00 and gave the company an “outperform” rating in a report on Friday, October 27th. Northcoast Research reaffirmed a “buy” rating and set a $230.00 price target (up previously from $200.00) on shares of Align Technology in a report on Tuesday, October 10th. Finally, Morgan Stanley raised their price target on shares of Align Technology from $257.00 to $300.00 and gave the company an “overweight” rating in a report on Monday, November 27th. Eleven investment analysts have rated the stock with a buy rating, Align Technology presently has a consensus rating of “Buy” and an average target price of $235.55.

In other Align Technology news, VP Emory Wright sold 5,025 shares of the firm’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $263.68, for a total transaction of $1,324,992.00. Following the sale, the vice president now owns 80,762 shares in the company, valued at approximately $21,295,324.16. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Joseph Lacob sold 29,724 shares of the firm’s stock in a transaction that occurred on Thursday, November 30th. The stock was sold at an average price of $260.91, for a total transaction of $7,755,288.84. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,849 shares of company stock worth $13,494,348. 1.60% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This article was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another website, it was stolen and republished in violation of international copyright laws. The correct version of this article can be accessed at https://stocknewstimes.com/2017/12/06/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-align-technology-algn-share-price.html.

Align Technology Company Profile

Align Technology, Inc designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment.

Insider Buying and Selling by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply